Company Filing History:
3 out of 441 
2 out of 79 Years Active: 2023-2025
Title: Shiho Kozuma: Innovator in Antibody Development
Introduction
Shiho Kozuma is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 3 patents to her name, her work is paving the way for innovative treatments in cancer therapy.
Latest Patents
Kozuma's latest patents focus on bispecific antibodies that serve as anti-tumor agents. One of her notable inventions describes an antibody that comprises a heavy chain CDRH1 consisting of SEQ ID NO: 54, a heavy chain CDRH2 consisting of SEQ ID NO: 55, and a heavy chain CDRH3 consisting of SEQ ID NO: 56. Additionally, it includes a light chain CDRL1 consisting of SEQ ID NO: 57 or a variant thereof, along with other specific light chain components. This innovative approach aims to enhance the efficacy of cancer treatments.
Career Highlights
Throughout her career, Kozuma has worked with esteemed organizations such as Daiichi Sankyo Company, Limited and Mie University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kozuma has had the opportunity to work alongside talented individuals, including Junya Ichikawa and Kensuke Nakamura. These collaborations have further enriched her research and development efforts in the biotechnology sector.
Conclusion
Shiho Kozuma's contributions to the field of bispecific antibodies highlight her innovative spirit and dedication to advancing cancer treatment. Her work continues to inspire future developments in biotechnology and medicine.